title: The use of tumor necrosis factor inhibitors in pregnancy: what is the evidence?
authors.affiliation: Baylor University Medical Center, Dallas, Texas.
authors.forename: Dario Nicolas
authors.initials: DN
authors.lastname: Kivelevitch
authors.affiliation: Baylor University Medical Center, Dallas, Texas.
authors.forename: Caitriona
authors.initials: C
authors.lastname: Ryan
authors.affiliation: Baylor University Medical Center, Dallas, Texas. Electronic address: amderm@gmail.com.
authors.forename: Alan
authors.initials: A
authors.lastname: Menter
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000517:prevention & control*; D003879:Dermatologic Agents / Q000009:adverse effects*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007774:Lactation / Q000187:drug effects*; D061214:Patient Safety; D011247:Pregnancy
chemical_list: D003879:Dermatologic Agents